Detalhe da pesquisa
1.
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.
Cell
; 170(6): 1109-1119.e10, 2017 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28886381
2.
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.
Cell
; 174(4): 1031-1032, 2018 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30096300
3.
Sotorasib for Lung Cancers with KRAS p.G12C Mutation.
N Engl J Med
; 384(25): 2371-2381, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34096690
4.
Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summary.
Future Oncol
; 20(3): 113-120, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38010044
5.
Phase 1b/2 study of blinatumomab in Japanese adults with relapsed/refractory acute lymphoblastic leukemia.
Cancer Sci
; 111(4): 1314-1323, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31971321
6.
A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia.
Am J Hematol
; 92(7): 660-667, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28370201
7.
Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study.
Lancet Oncol
; 15(9): 1007-18, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24965569
8.
Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial.
Nat Med
; 30(1): 265-270, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38177853
9.
Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non-Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100.
J Clin Oncol
; 41(18): 3311-3317, 2023 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37098232
10.
Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib.
Lung Cancer
; 166: 270-278, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838325
11.
Open-label, phase 2 study of blinatumomab after frontline R-chemotherapy in adults with newly diagnosed, high-risk DLBCL.
Leuk Lymphoma
; 63(9): 2063-2073, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35503708
12.
Brain regions engaged by part- and whole-task performance in a video game: a model-based test of the decomposition hypothesis.
J Cogn Neurosci
; 23(12): 3983-97, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21557648
13.
A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma.
BJU Int
; 108(5): 679-86, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21156020
14.
Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB-IVM1c melanoma.
J Immunother Cancer
; 9(3)2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785610
15.
Biomarkers associated with blinatumomab outcomes in acute lymphoblastic leukemia.
Leukemia
; 35(8): 2220-2231, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33542479
16.
A phase 1b study of blinatumomab in Japanese children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
Int J Hematol
; 112(2): 223-233, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32564243
17.
Phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in relapsed/refractory acute myeloid leukemia.
Blood Adv
; 3(13): 1939-1949, 2019 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31253596
18.
Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma.
J Clin Oncol
; 34(22): 2619-26, 2016 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27298410
19.
Identification of nutrient partitioning genes participating in rice grain filling by singular value decomposition (SVD) of genome expression data.
BMC Genomics
; 4(1): 26, 2003 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-12854976
20.
A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma.
Neuro Oncol
; 13(4): 437-46, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21297127